Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway

	Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway
	Jiang L; Wang P; Sun YJ; Wu YJ(伍一军)
刊名	Journal of Experimental & Clinical Cancer Research
	2019
卷号	38 页码:e265
内容类型	期刊论文
源URL	[http://ir.ioz.ac.cn/handle/000000/14090]
专题	农业虫害鼠害综合治理研究国家重点实验室
推荐引用方式 GB/T 7714	Jiang L,Wang P,Sun YJ,et al. Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway[J]. Journal of Experimental & Clinical Cancer Research,2019,38:e265.
APA	Jiang L,Wang P,Sun YJ,&伍一军.(2019).Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway.Journal of Experimental & Clinical Cancer Research,38,e265.
MLA	Jiang L,et al."Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway".Journal of Experimental & Clinical Cancer Research 38(2019):e265.